Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marusawa, H
Right arrow Articles by Chiba, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marusawa, H
Right arrow Articles by Chiba, T
Topic Collections
Right arrowRelated Article
Gut 1999;45:284-288 ( August )

Article

High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan H Marusawaa, Y Osakib, T Kimurab, K Itoc, Y Yamashitad, T Eguchie, M Kudof, Y Yamamotog, H Kojimac, H Senoa, F Moriyasua, T Chibaa

a Division of Gastroenterology and Hepatology, Department of Medicine, Postgraduate School of Medicine, Kyoto University, Kyoto, Japan, b Department of Gastroenterology, Osaka Red Cross Hospital, Osaka, Japan, c Department of Gastroenterology, Shizuoka General Hospital, Shizuoka, Japan, d Department of Gastroenterology, Kishiwada City Hospital, Osaka, Japan, e Department of Gastroenterology, Kitano Hospital, Osaka, Japan, f Department of Gastroenterology, Kobe City General Hospital, Hyogo, Japan, g Department of Gastroenterology, Takatsuki General Hospital, Osaka, Japan

Correspondence to: Dr T Chiba, Department of Gastroenterology and Hepatology, Department of Medicine, Postgraduate School of Medicine, Kyoto University, 54 Kawara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.

Accepted for publication 17 February 1999

BACKGROUND/AIMS---Evidence is accumulating that hepatitis B virus (HBV) is present in patients who are hepatitis B surface antigen negative but have antibody to hepatitis B core antigen (anti-HBc). Furthermore, recent studies have shown that patients with hepatocellular carcinoma who have antibody to hepatitis C virus (HCV) often possess HBV related serological markers. Data on the seroprevalence of HBV infection in patients with HCV related chronic liver disease were collected to evaluate the significance of the presence of antibodies to HBV.
METHODS---The prevalence of HBV related serological markers was analysed in a total of 2014 Japanese patients with HCV infection. The control group comprised 352 subjects without liver disorder.
RESULTS---A large number of patients (49.9%) with HCV related chronic liver disease including hepatocellular carcinoma were positive for anti-HBc. In addition, the prevalence of anti-HBc closely correlated with the clinical stage of the liver disease. There was no relation between a past history of blood transfusion and the prevalence of anti-HBc. Notably, anti-HBc was the only serological marker for HBV infection in a significant number of patients with HCV related chronic liver disease (24.1%).
CONCLUSIONS---Our data provide further evidence for the high prevalence of anti-HBc in patients with HCV related chronic liver disease, particularly those with hepatocellular carcinoma, suggesting that HBV infection, probably including latent infection, may play an important role in carcinogenesis in these patients.


Keywords: hepatitis B virus; anti-HBc; hepatitis C virus; hepatocellular carcinoma

© 1999 by Gut

Related Article

HBV + HCV = HCC?
M E CRAMP
Gut 1999 45: 168-169. [Extract] [Full Text]



This article has been cited by other articles:


Home page
 ANN INTERN MEDHome page
B. J. Veldt, E. J. Heathcote, H. Wedemeyer, J. Reichen, W. P. Hofmann, S. Zeuzem, M. P. Manns, B. E. Hansen, S. W. Schalm, and H. L.A. Janssen
Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis
Ann Intern Med, November 20, 2007; 147(10): 677 - 684.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
K. Ikeda, H. Marusawa, Y. Osaki, T. Nakamura, N. Kitajima, Y. Yamashita, M. Kudo, T. Sato, and T. Chiba
Antibody to Hepatitis B Core Antigen and Risk for Hepatitis C-Related Hepatocellular Carcinoma: A Prospective Study
Ann Intern Med, May 1, 2007; 146(9): 649 - 656.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. Santagostino, M. Colombo, M. Rivi, M. G. Rumi, A. Rocino, S. Linari, and P. M. Mannucci
A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus
Blood, July 1, 2003; 102(1): 78 - 82.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. J. Goedert, M. E. Eyster, M. M. Lederman, T. Mandalaki, P. de Moerloose, G. C. White II, A. L. Angiolillo, N. L. C. Luban, K. E. Sherman, M. Manco-Johnson, et al.
End-stage liver disease in persons with hemophilia and transfusion-associated infections
Blood, August 13, 2002; 100(5): 1584 - 1589.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
S D. A NISHIOKA;, H MARUSAWA, and T CHIBA
Acid secretion in H pylori associated enlarged fold gastritis.
Gut, August 1, 2000; 47(2): 313 - 314.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1999 BMJ Publishing Group Ltd & British Society of Gastroenterology